Program to Reduce Incontinence by Diet and Exercise
PRIDE
1 other identifier
interventional
338
1 country
4
Brief Summary
PRIDE will evaluate the impact of weight loss on urinary incontinence in a randomized, controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2004
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 21, 2004
CompletedFirst Posted
Study publicly available on registry
September 22, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2007
CompletedApril 16, 2020
April 1, 2020
3.3 years
September 21, 2004
April 14, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the number of incontinent episodes
Change in the number of incontinence episodes reported in a 7-day voiding diary from baseline to 6 months
6 months
Secondary Outcomes (3)
Change in body weight at 6 months
6 months
Change in body weight at 12 months
12 months
Change in body weight at 18 months
18 months
Study Arms (2)
Lifestyle & Behavioral Change Program
EXPERIMENTALStructured Education Program
ACTIVE COMPARATORInterventions
Participants in the weight loss arm will receive an intensive group-based behavioral weight loss program. In the first six months of the intervention, all participants in the weight loss arm will be given skill-based diet and exercise prescriptions for weight loss and will be taught specific cognitive and behavioral skills to assist in the modification of their eating and exercise habits. Participants will meet weekly for 6 months in group sessions led by a nutritionist, exercise physiologist, or behaviorist and will follow a structured protocol. This intervention strategy is modeled on interventions that have been successful in other overweight populations and is similar to the programs implemented in our ongoing studies, such as Look AHEAD. With this intervention, women are expected to lose on average of 7-9% of their initial body weight.
Women randomized to the Structured Education Program will be invited to participate in hour long group educational sessions at months 1, 2, 3, and 4. At months 6, 9 and 15, the groups will meet again for group support sessions. The content of these education and support sessions will include information about weight loss, physical activity, healthy eating habits and general health promotion. The educational sessions will be delivered primarily in a group format, with individual make up sessions provided for participants who miss group sessions.
Eligibility Criteria
You may qualify if:
- aged ≥ 30 years and not institutionalized
- body mass index 25 to 50 kg/m2
- urinary incontinence symptoms for \> 3 months by self-report and record \> 10 incontinent episodes per week on a 7-day urinary diary
- able to complete a behavioral run-in consisting of self-monitoring of food and activity
- report having a primary health care provider
- able to understand and sign informed consent and complete baseline questionnaires
- agree to not initiate new treatment for incontinence or weight reduction, including behavioral, pharmacological or surgical therapies, for the duration of the study
You may not qualify if:
- current use, or use within the previous month of medical therapy for incontinence
- currently pregnant or gave birth in the previous 6 months
- current urinary tract infection (dipstick urinalysis positive for leukocyte esterase, nitrites or blood) or report having \> 4 urinary tract infections in the preceding year
- incontinence of neurologic or functional origin (by history)
- self-report of prior anti-incontinence or urethral surgery, pelvic cancer or pelvic irradiation
- self-report of significant medical conditions of the genitourinary tract (genitourinary fistula, interstitial cystitis, symptomatic pelvic organ prolapse)
- report a medical condition that would affect the safety and/or efficacy of a weight management program involving diet and physical activity, including type 2 diabetes requiring medical therapy that may cause hypoglycemia, chronic steroid use or uncontrolled hypertension (systolic blood pressure \>180 mm Hg or diastolic blood pressure \> 100 mm Hg); women with a history of coronary heart disease may participate with written approval from their primary care physician
- currently engaged in an active weight loss program and/or experienced a 10% or greater weight reduction in the past 3 months
- report being unable to walk 2 blocks (1/4 mile) without stopping
- report conditions that, in the judgment of the Clinical Center Principal Investigator, render potential participants unlikely to follow the protocol for 18 months, including illness likely to be terminal within 2 years, plans to move, substance abuse or other significant psychiatric problems, or dementia
- participating in another research study that involves investigational drugs or can potentially confound the results of PRIDE
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
University of Alabama
Birmingham, Alabama, 35205, United States
University of Arkansas
Little Rock, Arkansas, 72205, United States
University of California at San Francisco
San Francisco, California, 94110, United States
Miriam Hospital/Brown University
Providence, Rhode Island, 02903, United States
Related Publications (8)
Myers DL, Sung VW, Richter HE, Creasman J, Subak LL. Prolapse symptoms in overweight and obese women before and after weight loss. Female Pelvic Med Reconstr Surg. 2012 Jan-Feb;18(1):55-9. doi: 10.1097/SPV.0b013e31824171f9.
PMID: 22453270DERIVEDPinto AM, Subak LL, Nakagawa S, Vittinghoff E, Wing RR, Kusek JW, Herman WH, West DS, Kuppermann M. The effect of weight loss on changes in health-related quality of life among overweight and obese women with urinary incontinence. Qual Life Res. 2012 Dec;21(10):1685-94. doi: 10.1007/s11136-011-0086-2. Epub 2011 Dec 10.
PMID: 22161726DERIVEDPinto AM, Kuppermann M, Nakagawa S, Vittinghoff E, Wing RR, Kusek JW, Herman WH, Subak LL. Comparison and correlates of three preference-based health-related quality-of-life measures among overweight and obese women with urinary incontinence. Qual Life Res. 2011 Dec;20(10):1655-62. doi: 10.1007/s11136-011-9896-5. Epub 2011 Apr 3.
PMID: 21461953DERIVEDWest DS, Gorin AA, Subak LL, Foster G, Bragg C, Hecht J, Schembri M, Wing RR; Program to Reduce Incontinence by Diet and Exercise (PRIDE) Research Group. A motivation-focused weight loss maintenance program is an effective alternative to a skill-based approach. Int J Obes (Lond). 2011 Feb;35(2):259-69. doi: 10.1038/ijo.2010.138. Epub 2010 Aug 3.
PMID: 20680012DERIVEDWing RR, Creasman JM, West DS, Richter HE, Myers D, Burgio KL, Franklin F, Gorin AA, Vittinghoff E, Macer J, Kusek JW, Subak LL; Program to Reduce Incontinence by Diet and Exercise (PRIDE). Improving urinary incontinence in overweight and obese women through modest weight loss. Obstet Gynecol. 2010 Aug;116(2 Pt 1):284-292. doi: 10.1097/AOG.0b013e3181e8fb60.
PMID: 20664387DERIVEDWing RR, West DS, Grady D, Creasman JM, Richter HE, Myers D, Burgio KL, Franklin F, Gorin AA, Vittinghoff E, Macer J, Kusek JW, Subak LL; Program to Reduce Incontinence by Diet and Exercise Group. Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol. 2010 Sep;184(3):1005-10. doi: 10.1016/j.juro.2010.05.031.
PMID: 20643425DERIVEDHuang AJ, Subak LL, Wing R, West DS, Hernandez AL, Macer J, Grady D; Program to Reduce Incontinence by Diet and Exercise Investigators. An intensive behavioral weight loss intervention and hot flushes in women. Arch Intern Med. 2010 Jul 12;170(13):1161-7. doi: 10.1001/archinternmed.2010.162.
PMID: 20625026DERIVEDSubak LL, Wing R, West DS, Franklin F, Vittinghoff E, Creasman JM, Richter HE, Myers D, Burgio KL, Gorin AA, Macer J, Kusek JW, Grady D; PRIDE Investigators. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009 Jan 29;360(5):481-90. doi: 10.1056/NEJMoa0806375.
PMID: 19179316DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah Grady, MD, PhD
UCSF Coordinating Center
- PRINCIPAL INVESTIGATOR
Leslee Subak, MD
UCSF Coordinating Center
- STUDY DIRECTOR
John Kusek, PhD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- STUDY DIRECTOR
Lee Nyberg, PhD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2004
First Posted
September 22, 2004
Study Start
July 1, 2004
Primary Completion
November 1, 2007
Study Completion
November 1, 2007
Last Updated
April 16, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will share
Data are available at the NIDDK Central Repository: https://repository.niddk.nih.gov/studies/pride/?query=pride